Filter
5710
Filtered Results: 5710
Text search:
disease
surveillance
Featured
Recommendations
539
New Publications
1546
Language
Document type
No document type
2976
Studies & Reports
974
Guidelines
867
Strategic & Response Plan
299
Manuals
249
Fact sheets
151
Situation Updates
82
Training Material
59
Resource Platforms
18
Infographics
18
Online Courses
9
Brochures
8
Countries / Regions
Global
228
India
189
Kenya
151
Sierra Leone
148
Liberia
141
Western and Central Europe
132
Africa
132
Ethiopia
120
Nigeria
110
Congo, Democratic Republic of
104
Latin America and the Carribbean
103
Uganda
101
South Africa
99
Nepal
84
Malawi
81
Rwanda
80
Guinea
73
Bangladesh
67
Zambia
62
Syria
62
Tanzania
62
West and Central Africa
62
Ghana
60
Senegal
57
Ukraine
54
Myanmar / Burma
49
South–East Asia Region
49
South Sudan
48
Eastern Europe
48
Philippines
47
Mozambique
45
East and Southern Africa
45
Brazil
44
Russia
43
Middle East and North Africa
39
Burkina Faso
37
Yemen
37
Germany
35
Namibia
35
Asia
35
Zimbabwe
34
Cambodia
31
Haiti
29
Indonesia
26
Madagascar
25
Mali
24
Cameroon
23
Pakistan
23
Lesotho
22
Botswana
21
Eastern Europe and Central Asia
21
Côte d’Ivoire / Ivory Coast
20
Venezuela
18
Western Pacific Region
17
Somalia
16
Afghanistan
16
Benin
15
Central African Republic
15
Eswatini/ Swaziland
15
Sudan
14
Colombia
14
Angola
14
Chad
13
Tajikistan
13
Niger
12
USA
11
Paraguay
11
Albania
11
Moldova
11
Thailand
10
Guinea-Bissau
9
Togo
9
North America
9
Iraq
8
Jordan
8
Argentina
8
Peru
8
Ecuador
8
Georgia
8
Papua New Guinea
7
Burundi
7
Bolivia
7
Mexico
7
Vietnam
7
Lebanon
6
Turkey
6
China
6
North Macedonia
6
Palestine
6
Armenia
6
Gambia
5
Chile
5
Southern Africa
5
Laos
5
Timor Leste/ East Timor
5
Iran
5
France
5
Spain
5
Saudi Arabia
4
Honduras
4
Sri Lanka
4
Egypt
3
Mauritania
3
Ireland
3
Libya
3
Bhutan
3
Djibouti
3
Congo-Brazzaville
3
Romania
3
Kyrgyzstan
3
Gabon
3
Turkmenistan
3
Mauritius
3
Portugal
3
Morocco
2
Greece
2
Other region
2
North Korea
2
Italy
2
Qatar
2
Bulgaria
2
Estonia
2
Uzbekistan
2
Kazakhstan
2
Belgium
2
Tunisia
2
Belarus
2
Bosnia and Herzegovina
2
Singapore
1
Vanuatu
1
Dominican Republic
1
Serbia
1
Hungary
1
El Salvador
1
Guatemala
1
Cape Verde
1
Nicaragua
1
Fiji
1
Solomon Islands
1
Poland
1
Canada
1
Slovakia
1
Australia
1
Uruguay
1
Jamaica
1
Japan
1
Denmark
1
Maldives
1
United Kingdom
1
Azerbaijan
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
2152
Clinical Guidelines
487
Public Health
320
Key Resources
221
Women & Child Health
159
Pharmacy & Technologies
79
Capacity Building
54
Toolboxes
COVID-19
741
HIV
444
TB
411
Rapid Response
344
Ebola
308
AMR
306
NTDs
221
Planetary Health
186
Mental Health
151
Conflict
116
NCDs
97
Caregiver
95
Zika
94
Global Health Education
78
Natural Hazards
74
Refugee
72
Cholera
65
Polio
62
Pharmacy
62
Disability
38
Health Financing Toolbox
33
Specific Hazards
26
Typhoon
4
Social Ethics
3
This document provides guidance on interventions to prevent vaccine-preventable disease outbreaks in the context of mass population movement resulting from the ongoing crisis in Ukraine.
Le choléra reste une menace mondiale pour la santé publique et un indicateur clé du
manque de développement social. La transmission du choléra est étroitement liée à
l’accès insuffisant à l’eau potable et à l’assainissement. Les zones typiques à risque sont
notamment les bido...
BMJ Open 2021;11:e042279. doi:10.1136/bmjopen-2020-042279. Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarray...
Chagas disease is currently endemic and also predicted to be at increased transmission risk under future climate change scenarios. Similarly, an expansion of areas in the United States at increased risk for Chagas ... transmission is also expected over the next several decades under climate change scenarios. Of particular interest is the predicted northern shift of triatomine species to central regions of the United States with historically unsuitable climates for T. cruzi vectors. The weight of evidence regarding the influences climate change may pose on T. cruzi vector species distributions demonstrates the sensitivity of Chagas disease transmission to future climate variability. In order to advance forecasts for the impact climate change may have on Chagas disease transmission in the Americas, it is imperative to
further develop, utilize, and perhaps combine predictive species distribution modeling approaches that integrate accurate, long term data on climate variables, vector species distributions, Chagas disease incidence, as well as other socio-ecological variables.
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Int...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional .... Despite prior perception of low NCDs mortality rates, current evidence suggests that SSA is now at the dawn of the epidemiological transition with contemporary double burden of disease from NCDs and communicable diseases. In SSA, cardiovascular diseases (CVDs) are the most frequent causes of NCDs deaths, responsible for approximately 13% of all deaths and 37% of all NCDs deaths. Although ischemic heart disease (IHD) has been identified as the leading cause of CVDs mortality in SSA followed by stroke and hypertensive heart disease from statistical models, real field data suggest IHD rates are still relatively low. The neglected endemic CVDs of SSA such as endomyocardial fibrosis and rheumatic heart disease as well as congenital heart diseases remain unconquered. While the underlying aetiology of heart failure among adults in high-income countries (HIC) is IHD, in SSA the leading causes are hypertensive heart disease, cardiomyopathy, rheumatic heart disease, and congenital heart diseases. Of concern is the tendency of CVDs to occur at younger ages in SSA populations, approximately two decades earlier compared to HIC. Obstacles hampering primary and secondary prevention of CVDs in SSA include insufficient health care systems and infrastructure, scarcity of cardiac professionals, skewed budget allocation and disproportionate prioritization away from NCDs, high cost of cardiac treatments and interventions coupled with rarity of health insurance systems. This review gives an overview of the descriptive epidemiology of CVDs in SSA, while contrasting with the HIC and highlighting impediments to their management and making recommendations.
The guide aims to provide health and DRM practitioners, planners and policymakers across sectors with targeted information to help them strengthen national health systems and integrate the risks of disease outbreaks in national DRR strategies
The...
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (...
The World Health Organization (WHO) Global Status Report on Noncommunicable Diseases 2010 projects that noncommunicable diseases (NCDs) will be responsible for over 44 million deaths during the next...
Policy Brief | April 2015 | This brief accompanies the data sheet, Addressing Risk Factors for Noncommunicable Diseases Among Young People in Africa: Key to Prevention and Sustainable Development, and its data appendix, which provide all available c...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD di.... Affordable essential medicines and technologies to manage CVD disease must be available where and when they are required. Medicines and technologies need to be managed appropriately to ensure that the correct medicines are selected, procured in the right quantities, distributed to facilities in a timely manner, and handled and stored in a way that maintains their quality. This needs to be backed up by policies that enable sufficient quantities to be procured in order to reduce cost inefficiencies, ensure the reliability and security of the distribution system, and encourage the appropriate use of these health products. In order to avoid stock-outs and the disruption of treatment, all related activities need to be conducted in a timely manner, with performance continually monitored, and prompt action taken in response to problems that may arise. Additionally, medication must be dispensed correctly and used rationally by the healthcare provider and patient alike. The purpose of this guide is to explain the necessary steps.
Cancer, diabetes, heart disease and stroke, chronic respiratory disease
Updated September 2014
